Effect of androgen structures on the inhibition of metyraponeinreductase in rat, mouse, and human liver.
Nagamine
S
S
Kobe Pharmaceutical University, Japan.
Yamagami
C
C
Hirai
Y
Y
Iwakawa
S
S
D000429:Alcohol Oxidoreductases / Q000037:antagonists & inhibitors*; D000728:Androgens / Q000737:chemistry* / Q000378:metabolism; D000818:Animals; D001462:Barbital; D006801:Humans; D007664:Ketosteroids / Q000378:metabolism; D008099:Liver / Q000201:enzymology*; D008797:Metyrapone / Q000737:chemistry* / Q000378:metabolism; D051379:Mice; D008862:Microsomes, Liver / Q000201:enzymology; D008958:Models, Molecular; D015394:Molecular Structure; D010084:Oxidation-Reduction; D011720:Pyrazoles; D011794:Quercetin / Q000031:analogs & derivatives; D051381:Rats; D013329:Structure-Activity Relationship
D000728:Androgens; D007664:Ketosteroids; D011720:Pyrazoles; C012526:quercitrin; D001462:Barbital; D011794:Quercetin; D000429:Alcohol Oxidoreductases; C073803:metyrapone reductase; D008797:Metyrapone